Evaluating Extracorporeal Membrane Oxygenation and Ventilation Treatment of Patients with COVID-19: A Review
Archives of Medical Laboratory Sciences,
Vol. 6 (2020),
20 January 2020
,
Page 1-6 (e16)
https://doi.org/10.22037/amls.v6.33550
Abstract
The prevalence of COVID-19 in the world is rapidly increasing. Although some patients show mild symptoms of the virus, some others need special care due to the exacerbation of the disease. Therefore, invasive treatments are needed to treat these patients. Data were collected from PubMed and Google scholars at various time points up to the 2020 academic year. The related keywords are listed as follows: "COVID-19", "Treatment", "Pathogenesis", and "Lung disorder". Studies have shown that although the use of ECMO and ventilation can provide oxygen to patients and improve their clinical status; these procedures can lead to the activation of inflammatory responses and the activation of the renin-angiotensin system. Inflammation and activation of the renin-angiotensin system are among the weak prognoses for COVID-19-infected patients. ECMO and ventilation treatment procedures are like double-edged swords, and monitoring patients during treatment is essential to prevent renin-angiotensin activation.
*Corresponding Author: Zahra Gatavizadeh; Email: z-gatavizadeh@ajums.ac.ir
Please cite this article as: Hybar H, Samimi A, Maniati M, Jodat J, Gatavizadeh Z. Evaluating Extracorporeal Membrane Oxygenation and Ventilation Treatment of Patients with COVID-19: A Review. Arch Med Lab Sci. 2020;6:1-6 (e16). https://doi.org/10.22037/amls.v6.33550
- Coronavirus disease
- Extracorporeal membrane oxygenation
- ECMO
- Ventilation
- Lung disorder
- Renin-angiotensin system
- COVID-19
How to Cite
References
Savarese G, Lund LH. Global public health burden of heart failure. Cardiac failure review. 2017;3(1):7.
Borlaug BA. The pathophysiology of heart failure with preserved ejection fraction. Nature Reviews Cardiology. 2014;11(9):507.
Rahman F, Kwan GF, Benjamin EJ. Global epidemiology of atrial fibrillation. Nature Reviews Cardiology. 2014;11(11):639.
Simmers MB, Cole BK, Ogletree ML, Chen Z, Xu Y, Kong L-j, et al. Hemodynamics associated with atrial fibrillation directly alters thrombotic potential of endothelial cells. Thrombosis research. 2016;143:34-9.
Erdil N, Gedik E, Donmez K, Erdil F, Aldemir M, Battaloglu B, et al. Predictors of postoperative atrial fibrillation after on-pump coronary artery bypass grafting: is duration of mechanical ventilation time a risk factor? Annals of Thoracic and Cardiovascular Surgery. 2014;20(2):135-42.
Laksman Z, Wauchop M, Lin E, Protze S, Lee J, Yang W, et al. Modeling atrial fibrillation using human embryonic stem cell-derived atrial tissue. Scientific reports. 2017;7(1):1-11.
Fisher SA, Doree C, Mathur A, Taggart DP, Martin‐Rendon E. Stem cell therapy for chronic ischaemic heart disease and congestive heart failure. Cochrane Database of Systematic Reviews. 2016(12).
Abazari O, Divsalar A, Ghobadi R. Inhibitory effects of oxali-Platin as a chemotherapeutic drug on the function and structure of bovine liver catalase. Journal of Biomolecular Structure and Dynamics. 2019:1-7.
Caplan AI. Mesenchymal stem cells: time to change the name! Stem cells translational medicine. 2017;6(6):1445-51.
Shafaei Z, Abazari O, Divsalar A, Ghalandari B, Poursoleiman A, Saboury AA, et al. Effect of a Synthesized Amyl-Glycine1, 10-Phenanthroline Platinum Nitrate on Structure and Stability of Human Blood Carrier Protein, Albumin: Spectroscopic and Modeling Approaches. Journal of fluorescence. 2017;27(5):1829-38.
Guo X, Bai Y, Zhang L, Zhang B, Zagidullin N, Carvalho K, et al. Cardiomyocyte differentiation of mesenchymal stem cells from bone marrow: new regulators and its implications. Stem cell research & therapy. 2018;9(1):44.
Abazari O, Divsalar A, Ghobadi R. Inhibitory effects of oxali-Platin as a chemotherapeutic drug on the function and structure of bovine liver catalase. Journal of Biomolecular Structure and Dynamics. 2020;38(2):609-15.
Ward MR, Abadeh A, Connelly KA. Concise review: rational use of mesenchymal stem cells in the treatment of ischemic heart disease. Stem cells translational medicine. 2018;7(7):543-50.
Rossignol P, Hernandez AF, Solomon SD, Zannad F. Heart failure drug treatment. The Lancet. 2019;393(10175):1034-44.
Abazari O, Shafaei Z, Divsalar A, Eslami-Moghadam M, Ghalandari B, Saboury AA. Probing the biological evaluations of a new designed Pt (II) complex using spectroscopic and theoretical approaches: Human hemoglobin as a target. Journal of Biomolecular Structure and Dynamics. 2016;34(5):1123-31.
Smith ED, Tome J, Mcgrath R, Kumar S, Concannon M, Day SM, et al. Exercise hemodynamics in hypertrophic cardiomyopathy identify risk of incident heart failure but not ventricular arrhythmias or sudden cardiac death. International journal of cardiology. 2019;274:226-31.
Hemmeryckx B, Feng Y, Frederix L, Lox M, Trenson S, Vreeken R, et al. Evaluation of cardiac arrhythmic risks using a rabbit model of left ventricular systolic dysfunction. European journal of pharmacology. 2018;832:145-55.
Asadi A, Nezhad DY, Javazm AR, Khanicheragh P, Mashouri L, Shakeri F, et al. In vitro Effects of Curcumin on Transforming Growth Factor-β-mediated Non-Smad Signaling Pathway, Oxidative Stress, and Pro‐inflammatory Cytokines Production with Human Vascular Smooth Muscle Cells. Iranian Journal of Allergy, Asthma and Immunology. 2019:1-10.
Yu H, Zhang N, Zhu J, Ma Q, Zhao Y, Wang Y, et al. Exosomes derived from human umbilical cord MSCs rejuvenate aged MSCs and enhance their functions for myocardial repair. 2020.
Abazari O, Shafaei Z, Divsalar A, Eslami-Moghadam M, Ghalandari B, Saboury AA, et al. Interaction of the synthesized anticancer compound of the methyl-glycine 1, 10-phenanthroline platinum nitrate with human serum albumin and human hemoglobin proteins by spectroscopy methods and molecular docking. Journal of the Iranian Chemical Society. 2020:1-14.
Wang D, Zhang F, Shen W, Chen M, Yang B, Zhang Y, et al. Mesenchymal stem cell injection ameliorates the inducibility of ventricular arrhythmias after myocardial infarction in rats. International journal of cardiology. 2011;152(3):314-20.
Hare JM, Traverse JH, Henry TD, Dib N, Strumpf RK, Schulman SP, et al. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. Journal of the American College of Cardiology. 2009;54(24):2277-86.
Mills WR, Mal N, Kiedrowski MJ, Unger R, Forudi F, Popovic ZB, et al. Stem cell therapy enhances electrical viability in myocardial infarction. Journal of molecular and cellular cardiology. 2007;42(2):304-14.
Abbasi M, Abazari OO. Probing the Biological evaluations of a new designed Palladium (II) complex using spectroscopic and theoretical approaches: Human Hemoglobin as a Target. Archives of Medical Laboratory Sciences. 2018;3(3).
Lin H, Sohn J, Shen H, Langhans MT, Tuan RS. Bone marrow mesenchymal stem cells: Aging and tissue engineering applications to enhance bone healing. Biomaterials. 2019;203:96-110.
Asumda FZ, Chase PB. Age-related changes in rat bone-marrow mesenchymal stem cell plasticity. BMC cell biology. 2011;12(1):44.
- Abstract Viewed: 75 times
- PDF Downloaded: 58 times